How much cash does Royalty Pharma generate?

Royalty Pharma (RPRX) generated $2.6B in operating cash flow over the trailing twelve months.

Where does Royalty Pharma's cash flow data come from?

Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Royalty Pharma RPRX Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net cash from operating activities	$2.49B-10.1%	$2.77B-7.3%	$2.99B+39.4%	$2.14B+6.3%
Net cash from investing activities	-$1.61B+39.7%	-$2.68B-29.2%	-$2.07B—	——
Repurchases of common stock	$1.23B+434%	$229.65M—	——	——
Net cash from financing activities	——	——	-$2.15B-127%	-$944.86M—
Net increase (decrease) in cash	-$310.33M—	——	-$1.23B-827%	$169.7M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Royalty Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Royalty Pharma generate?: Royalty Pharma (RPRX) generated $2.6B in operating cash flow over the trailing twelve months.
Where does Royalty Pharma's cash flow data come from?: Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.